Colorectal cancer laboratory news

<p>Presentation of Gemma Turon. Image: El Periódico</p>
15 May 2018

El Periódico newspaper has published an article about “Pint of Science”, a science festival that took place on Monday at the same time and in different bars around the city of Barcelona. It also included a picture of the presentation given by Gemma Turon, PhD student with the Colorectal Cancer lab at IRB Barcelona.

Link to El Periódico

<p>Eduard Battle with the members of the Colorectal Cancer Lab at IRB Barcelona</p>
10 Apr 2018

The IRB Barcelona scientist and head of the Colorectal Cancer Lab has been awarded the Olof Palme Medal in recognition of his recent discovery regarding the treatment of advanced-stage colon tumors with immunotherapy.

<p>Eduard Batlle, head of the Colorectal Cancer laboratory at IRB Barcelona</p>
4 Apr 2018

The website SelectScience has published an article about research headed by Eduard Batlle, head of the Colorectal Cancer Lab at IRB Barcelona, on the effectiveness of treatments that enhance immune system function in colon cancer.

Link to SelectScience

<p>ICREA research professor Eduard Batlle</p>
4 Apr 2018

The newspaper El País has published an article about a scientific study that reveals that immunotherapy with antibodies prevents cancer from evading natural killer cells. The article includes statements by Eduard Batlle, head of the Colorectal Cancer Lab at IRB Barcelona, as an external expert.

Link to El País

<p>Joan Massagué, director of the Sloan Kettering Institute of New York. Image: Jordi Casañas (Mahala, IRB Barcelona)</p>
15 Mar 2018

High-ranking figures from the business and innovation sectors attended an event organised by IRB Barcelona and ESADE with the aim to highlight the importance of uniting all sectors of society against metastasis.

<p>Colon cancer stem cells, in green (G. Turon, IRB Barcelona)</p>
13 Mar 2018

Advances in research into the immunological evasion, metabolism and latency of metastatic cancer cells allow the identification of potential targets to test therapies.

IRB Barcelona and the BBVA Foundation invite 20 renowned international scientists working in the field of cancer metastasis to a gathering in Barcelona.

After the scientific conference, IRB Barcelona and ESADE have organised a debate on how to translate scientific research to society.

12 Mar 2018

Postdoc Daniele Tauriello (Oss, Netherlands; 1981) is the first author of a recent scientific breakthrough at IRB Barcelona: the key role of TGFβ in hiding colorectal tumours from the immune system. In this interview he tells us about the work behind this study, led by Eduard Batlle and done in collaboration with Antoni Riera’s lab and Camille Stephan-Otto Attolini’s unit, that has just been published in Nature.

The road to this discovery has been long and hard at times. It has taken more than four years for the team to generate the right mouse models, performing more than 15 generations of crossings, adding mutations one by one to achieve models with very aggressive (and...

<p>Eduard Batlle, head of the Colorectal Cancer Laboratory at IRB Barcelona</p>
19 Feb 2018

TV3, RTVE, Rac1, La Vanguardia, and Ara, among other important media, have published articles about research led by Eduard Batlle, head of the Colorectal Cancer Laboratory at IRB Barcelona, on the effectiveness of treatments that enhance immune system function in colon cancer.

Link to ABC

Link to El Punt Avui

<p>ICREA reserach professor Eduard Batlle</p>
19 Feb 2018

The ABC newspaper interviewed Eduard Batlle, about his latest work published in the journal Nature, in which he has managed to cure colon cancer in mice by unblocking the immune system to act against the disease.

Link to ABC

<p>The image shows a metastatic colon tumour infiltrated by the immune system (brown) after combined treatment with the TGF-beta inhibitor and immunotherapy.  (Author: Daniele Tauriello, IRB Barcelona)</p>
14 Feb 2018

A team headed by ICREA researcher Eduard Batlle discovers that immune system-stimulating treatments combined with a TGF-beta inhibitor are effective against colon cancer.

The researchers developed a mouse model that mimics advanced human colon cancer. This model has allowed them to study the immune system response for the first time.